<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26694447</PMID><DateCompleted><Year>2016</Year><Month>09</Month><Day>29</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>21</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>12</Issue><PubDate><Year>2015</Year><Month>Dec</Month><Day>14</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>Innate Immunity and Immune Evasion by Enterovirus 71.</ArticleTitle><Pagination><StartPage>6613</StartPage><EndPage>6630</EndPage><MedlinePgn>6613-30</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3390/v7122961</ELocationID><Abstract><AbstractText>Enterovirus 71 (EV71) is a major infectious disease affecting millions of people worldwide and it is the main etiological agent for outbreaks of hand foot and mouth disease (HFMD). Infection is often associated with severe gastroenterological, pulmonary, and neurological diseases that are most prevalent in children. Currently, no effective vaccine or antiviral drugs exist against EV71 infection. A lack of knowledge on the molecular mechanisms of EV71 infection in the host and the virus-host interactions is a major constraint to developing specific antiviral strategies against this infection. Previous studies have identified and characterized the function of several viral proteins produced by EV71 that interact with the host innate immune proteins, including type I interferon signaling and microRNAs. These interactions eventually promote efficient viral replication and increased susceptibility to the disease. In this review we discuss the functions of EV71 viral proteins in the modulation of host innate immune responses to facilitate viral replication.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pathinayake</LastName><ForeName>Prabuddha S</ForeName><Initials>PS</Initials><AffiliationInfo><Affiliation>Priority Research Centre for Asthma and Respiratory Disease, University of Newcastle and Hunter Medical Research Institute, New South Wales 2305, Australia. prabuddha.pathinayake@uon.edu.au.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hsu</LastName><ForeName>Alan C-Y</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Priority Research Centre for Asthma and Respiratory Disease, University of Newcastle and Hunter Medical Research Institute, New South Wales 2305, Australia. alan.hsu@newcastle.edu.au.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wark</LastName><ForeName>Peter A B</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>Priority Research Centre for Asthma and Respiratory Disease, University of Newcastle and Hunter Medical Research Institute, New South Wales 2305, Australia. peter.wark@hnehealth.nsw.gov.au.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Respiratory and Sleep Medicine, John Hunter Hospital, New South Wales 2305, Australia. peter.wark@hnehealth.nsw.gov.au.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>12</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006232" MajorTopicYN="N">Hand, Foot and Mouth Disease</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054884" MajorTopicYN="Y">Host-Pathogen Interactions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057131" MajorTopicYN="Y">Immune Evasion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007113" MajorTopicYN="Y">Immunity, Innate</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Enterovirus 71</Keyword><Keyword MajorTopicYN="N">Interferon antagonist</Keyword><Keyword MajorTopicYN="N">J0101</Keyword><Keyword MajorTopicYN="N">innate immunity</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>9</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2015</Year><Month>11</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>12</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>12</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>12</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>9</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2015</Year><Month>12</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26694447</ArticleId><ArticleId IdType="pmc">PMC4690884</ArticleId><ArticleId IdType="doi">10.3390/v7122961</ArticleId><ArticleId IdType="pii">v7122961</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Brown B.A., Pallansch M.A. Complete nucleotide sequence of enterovirus 71 is distinct from poliovirus. Virus Res. 1995;39:195&#x2013;205. doi: 10.1016/0168-1702(95)00087-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0168-1702(95)00087-9</ArticleId><ArticleId IdType="pubmed">8837884</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon T., Lewthwaite P., Perera D., Cardosa M.J., McMinn P., Ooi M.H. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect. Dis. 2010;10:778&#x2013;790. doi: 10.1016/S1473-3099(10)70194-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(10)70194-8</ArticleId><ArticleId IdType="pubmed">20961813</ArticleId></ArticleIdList></Reference><Reference><Citation>Schenten D., Medzhitov R. The control of adaptive immune responses by the innate immune system. Adv. Immunol. 2011;109:87&#x2013;124.</Citation><ArticleIdList><ArticleId IdType="pubmed">21569913</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar H., Kawai T., Akira S. Pathogen recognition by the innate immune system. Int. Rev. Immunol. 2011;30:16&#x2013;34. doi: 10.3109/08830185.2010.529976.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/08830185.2010.529976</ArticleId><ArticleId IdType="pubmed">21235323</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumagai Y., Takeuchi O., Akira S. Pathogen recognition by innate receptors. J. Infect. Chemother. 2008;14:86&#x2013;92. doi: 10.1007/s10156-008-0596-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10156-008-0596-1</ArticleId><ArticleId IdType="pubmed">18622669</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawai T., Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity. 2011;34:637&#x2013;650. doi: 10.1016/j.immuni.2011.05.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2011.05.006</ArticleId><ArticleId IdType="pubmed">21616434</ArticleId></ArticleIdList></Reference><Reference><Citation>Land W.G. The Role of Damage-Associated Molecular Patterns in Human Diseases: Part I&#x2014;Promoting inflammation and immunity. Sultan Qaboos Univ. Med. J. 2015;15:e9&#x2013;e21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4318613</ArticleId><ArticleId IdType="pubmed">25685392</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeuchi O., Akira S. Innate immunity to virus infection. Immunol. Rev. 2009;227:75&#x2013;86. doi: 10.1111/j.1600-065X.2008.00737.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-065X.2008.00737.x</ArticleId><ArticleId IdType="pmc">PMC5489343</ArticleId><ArticleId IdType="pubmed">19120477</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrilli V., Dostert C., Muruve D.A., Tschopp J. The inflammasome: A danger sensing complex triggering innate immunity. Curr. Opin. Immunol. 2007;19:615&#x2013;622. doi: 10.1016/j.coi.2007.09.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coi.2007.09.002</ArticleId><ArticleId IdType="pubmed">17977705</ArticleId></ArticleIdList></Reference><Reference><Citation>Ooi M.H., Wong S.C., Lewthwaite P., Cardosa M.J., Solomon T. Clinical features, diagnosis, and management of enterovirus 71. Lancet Neurol. 2010;9:1097&#x2013;1105. doi: 10.1016/S1474-4422(10)70209-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(10)70209-X</ArticleId><ArticleId IdType="pubmed">20965438</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C.C., Tseng H.W., Wang S.M., Wang J.R., Su I.J. An outbreak of enterovirus 71 infection in Taiwan, 1998: Epidemiologic and clinical manifestations. J. Clin. Virol. 2000;17:23&#x2013;30. doi: 10.1016/S1386-6532(00)00068-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1386-6532(00)00068-8</ArticleId><ArticleId IdType="pubmed">10814935</ArticleId></ArticleIdList></Reference><Reference><Citation>Merovitz L., Demers A.M., Newby D., McDonald J. Enterovirus 71 infections at a Canadian center. Pediatr. Infect. Dis. J. 2000;19:755&#x2013;757. doi: 10.1097/00006454-200008000-00017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00006454-200008000-00017</ArticleId><ArticleId IdType="pubmed">10959747</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu F., Yao P.P., Xia Y., Qian L., Yang Z.N., Xie R.H., Sun Y.S., Lu H.J., Miao Z.P., Li C., et al. Enterovirus 71 infection causes severe pulmonary lesions in gerbils, merionesunguiculatus, which can be prevented by passive immunization with specific antisera. PLoS ONE. 2015;10:e0119173. doi: 10.1371/journal.pone.0119173.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0119173</ArticleId><ArticleId IdType="pmc">PMC4359154</ArticleId><ArticleId IdType="pubmed">25767882</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Cui W., Liu L., Wang J., Zhao H., Liao Y., Na R., Dong C., Wang L., Xie Z., et al. Pathogenesis study of enterovirus 71 infection in rhesus monkeys. Lab. Investig. 2011;91:1337&#x2013;1350. doi: 10.1038/labinvest.2011.82.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/labinvest.2011.82</ArticleId><ArticleId IdType="pubmed">21555996</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang S.W., Lee Y.P., Hung Y.T., Lin C.H., Chuang J.I., Lei H.Y., Su I.J., Yu C.K. Exogenous interleukin-6, interleukin-13, and interferon-gamma provoke pulmonary abnormality with mild edema in enterovirus 71-infected mice. Respir. Res. 2011;12 doi: 10.1186/1465-9921-12-147.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1465-9921-12-147</ArticleId><ArticleId IdType="pmc">PMC3223501</ArticleId><ArticleId IdType="pubmed">22054060</ArticleId></ArticleIdList></Reference><Reference><Citation>Hornung V., Ellegast J., Kim S., Brzozka K., Jung A., Kato H., Poeck H., Akira S., Conzelmann K.K., Schlee M., et al. 5&#x2032;-Triphosphate RNA is the ligand for RIG-I. Science. 2006;314:994&#x2013;997. doi: 10.1126/science.1132505.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1132505</ArticleId><ArticleId IdType="pubmed">17038590</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato H., Takeuchi O., Sato S., Yoneyama M., Yamamoto M., Matsui K., Uematsu S., Jung A., Kawai T., Ishii K.J., et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature. 2006;441:101&#x2013;105. doi: 10.1038/nature04734.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature04734</ArticleId><ArticleId IdType="pubmed">16625202</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng Q., Hato S.V., Langereis M.A., Zoll J., Virgen-Slane R., Peisley A., Hur S., Semler B.L., van Rij R.P., van Kuppeveld F.J. MDA5 detects the double-stranded RNA replicative form in picornavirus-infected cells. Cell Rep. 2012;2:1187&#x2013;1196. doi: 10.1016/j.celrep.2012.10.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2012.10.005</ArticleId><ArticleId IdType="pmc">PMC7103987</ArticleId><ArticleId IdType="pubmed">23142662</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoneyama M., Kikuchi M., Natsukawa T., Shinobu N., Imaizumi T., Miyagishi M., Taira K., Akira S., Fujita T. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 2004;5:730&#x2013;737. doi: 10.1038/ni1087.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni1087</ArticleId><ArticleId IdType="pubmed">15208624</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoneyama M., Kikuchi M., Matsumoto K., Imaizumi T., Miyagishi M., Taira K., Foy E., Loo Y.M., Gale M., Jr., Akira S., et al. Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J. Immunol. 2005;175:2851&#x2013;2858. doi: 10.4049/jimmunol.175.5.2851.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.175.5.2851</ArticleId><ArticleId IdType="pubmed">16116171</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato H., Takeuchi O., Mikamo-Satoh E., Hirai R., Kawai T., Matsushita K., Hiiragi A., Dermody T.S., Fujita T., Akira S. Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. J. Exp. Med. 2008;205:1601&#x2013;1610. doi: 10.1084/jem.20080091.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20080091</ArticleId><ArticleId IdType="pmc">PMC2442638</ArticleId><ArticleId IdType="pubmed">18591409</ArticleId></ArticleIdList></Reference><Reference><Citation>Seth R.B., Sun L., Ea C.K., Chen Z.J. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-&#x3ba;B and IRF 3. Cell. 2005;122:669&#x2013;682. doi: 10.1016/j.cell.2005.08.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2005.08.012</ArticleId><ArticleId IdType="pubmed">16125763</ArticleId></ArticleIdList></Reference><Reference><Citation>Potter J.A., Randall R.E., Taylor G.L. Crystal structure of human IPS-1/MAVS/VISA/Cardifcaspase activation recruitment domain. BMC Struct. Biol. 2008;8 doi: 10.1186/1472-6807-8-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1472-6807-8-11</ArticleId><ArticleId IdType="pmc">PMC2291057</ArticleId><ArticleId IdType="pubmed">18307765</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzgerald K.A., McWhirter S.M., Faia K.L., Rowe D.C., Latz E., Golenbock D.T., Coyle A.J., Liao S.M., Maniatis T. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 2003;4:491&#x2013;496. doi: 10.1038/ni921.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni921</ArticleId><ArticleId IdType="pubmed">12692549</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeuchi O., Akira S. MDA5/RIG-I and virus recognition. Curr. Opin. Immunol. 2008;20:17&#x2013;22. doi: 10.1016/j.coi.2008.01.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coi.2008.01.002</ArticleId><ArticleId IdType="pubmed">18272355</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohta A., Nishiyama Y. Mitochondria and viruses. Mitochondrion. 2011;11:1&#x2013;12. doi: 10.1016/j.mito.2010.08.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mito.2010.08.006</ArticleId><ArticleId IdType="pmc">PMC7105242</ArticleId><ArticleId IdType="pubmed">20813204</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang Y., Zhou Y., Shen P. NF-kappaB and its regulation on the immune system. Cell. Mol. Immunol. 2004;1:343&#x2013;350.</Citation><ArticleIdList><ArticleId IdType="pubmed">16285893</ArticleId></ArticleIdList></Reference><Reference><Citation>Oshiumi H., Okamoto M., Fujii K., Kawanishi T., Matsumoto M., Koike S., Seya T. The TLR3/TICAM-1 pathway is mandatory for innate immune responses to poliovirus infection. J. Immunol. 2011;187:5320&#x2013;5327. doi: 10.4049/jimmunol.1101503.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1101503</ArticleId><ArticleId IdType="pubmed">21998457</ArticleId></ArticleIdList></Reference><Reference><Citation>Abe Y., Fujii K., Nagata N., Takeuchi O., Akira S., Oshiumi H., Matsumoto M., Seya T., Koike S. The toll-like receptor 3-mediated antiviral response is important for protection against poliovirus infection in poliovirus receptor transgenic mice. J. Virol. 2012;86:185&#x2013;194. doi: 10.1128/JVI.05245-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.05245-11</ArticleId><ArticleId IdType="pmc">PMC3255933</ArticleId><ArticleId IdType="pubmed">22072781</ArticleId></ArticleIdList></Reference><Reference><Citation>Richer M.J., Lavallee D.J., Shanina I., Horwitz M.S. Toll-like receptor 3 signaling on macrophages is required for survival following coxsackievirus B4 infection. PLoS ONE. 2009;4:e4127. doi: 10.1371/journal.pone.0004127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0004127</ArticleId><ArticleId IdType="pmc">PMC2606033</ArticleId><ArticleId IdType="pubmed">19122812</ArticleId></ArticleIdList></Reference><Reference><Citation>Negishi H., Osawa T., Ogami K., Ouyang X., Sakaguchi S., Koshiba R., Yanai H., Seko Y., Shitara H., Bishop K., et al. A critical link between Toll-like receptor 3 and type II interferon signaling pathways in antiviral innate immunity. Proc. Natl. Acad. Sci. USA. 2008;105:20446&#x2013;20451. doi: 10.1073/pnas.0810372105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0810372105</ArticleId><ArticleId IdType="pmc">PMC2629334</ArticleId><ArticleId IdType="pubmed">19074283</ArticleId></ArticleIdList></Reference><Reference><Citation>Hacker H., Redecke V., Blagoev B., Kratchmarova I., Hsu L.C., Wang G.G., Kamps M.P., Raz E., Wagner H., Hacker G., et al. Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6. Nature. 2006;439:204&#x2013;207. doi: 10.1038/nature04369.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature04369</ArticleId><ArticleId IdType="pubmed">16306937</ArticleId></ArticleIdList></Reference><Reference><Citation>Stark G.R., Darnell J.E., Jr. The JAK-STAT pathway at twenty. Immunity. 2012;36:503&#x2013;514. doi: 10.1016/j.immuni.2012.03.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2012.03.013</ArticleId><ArticleId IdType="pmc">PMC3909993</ArticleId><ArticleId IdType="pubmed">22520844</ArticleId></ArticleIdList></Reference><Reference><Citation>Ivashkiv L.B., Donlin L.T. Regulation of type I interferon responses. Nat. Rev. Immunol. 2014;14:36&#x2013;49. doi: 10.1038/nri3581.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3581</ArticleId><ArticleId IdType="pmc">PMC4084561</ArticleId><ArticleId IdType="pubmed">24362405</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S., Yamashita Y., Li J., Hanagata N., Minowa T., Takemura T., Koike S. Scavenger receptor B2 is a cellular receptor for enterovirus 71. Nat. Med. 2009;15:798&#x2013;801. doi: 10.1038/nm.1992.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.1992</ArticleId><ArticleId IdType="pubmed">19543282</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang B., Chuang H., Yang K.D. Sialylatedglycans as receptor and inhibitor of enterovirus 71 infection to DLD-1 intestinal cells. Virol. J. 2009;6:141. doi: 10.1186/1743-422X-6-141.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-6-141</ArticleId><ArticleId IdType="pmc">PMC2751754</ArticleId><ArticleId IdType="pubmed">19751532</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin J.Y., Chen T.C., Weng K.F., Chang S.C., Chen L.L., Shih S.R. Viral and host proteins involved in picornavirus life cycle. J. Biomed. Sci. 2009;16 doi: 10.1186/1423-0127-16-103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1423-0127-16-103</ArticleId><ArticleId IdType="pmc">PMC2785775</ArticleId><ArticleId IdType="pubmed">19925687</ArticleId></ArticleIdList></Reference><Reference><Citation>Kontsek P. Human type I interferons: Structure and function. ActaVirol. 1994;38:345&#x2013;360.</Citation><ArticleIdList><ArticleId IdType="pubmed">7793359</ArticleId></ArticleIdList></Reference><Reference><Citation>Parmar S., Platanias L.C. Interferons: Mechanisms of action and clinical applications. Curr. Opin. Oncol. 2003;15:431&#x2013;439. doi: 10.1097/00001622-200311000-00005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00001622-200311000-00005</ArticleId><ArticleId IdType="pubmed">14624225</ArticleId></ArticleIdList></Reference><Reference><Citation>Takaoka A., Yanai H. Interferon signalling network in innate defence. Cell. Microbiol. 2006;8:907&#x2013;922. doi: 10.1111/j.1462-5822.2006.00716.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1462-5822.2006.00716.x</ArticleId><ArticleId IdType="pubmed">16681834</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadler A.J., Williams B.R. Interferon-inducible antiviral effectors. Nat. Rev. Immunol. 2008;8:559&#x2013;568. doi: 10.1038/nri2314.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri2314</ArticleId><ArticleId IdType="pmc">PMC2522268</ArticleId><ArticleId IdType="pubmed">18575461</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi L., He Y., Chen Y., Kung H.F., He M.L. Potent inhibition of human enterovirus 71 replication by type I interferon subtypes. Antivir. Ther. 2011;16:51&#x2013;58. doi: 10.3851/IMP1720.</Citation><ArticleIdList><ArticleId IdType="doi">10.3851/IMP1720</ArticleId><ArticleId IdType="pubmed">21311108</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu M.L., Lee Y.P., Wang Y.F., Lei H.Y., Liu C.C., Wang S.M., Su I.J., Wang J.R., Yeh T.M., Chen S.H., et al. Type I interferons protect mice against enterovirus 71 infection. J. Gen. Virol. 2005;86:3263&#x2013;3269. doi: 10.1099/vir.0.81195-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.81195-0</ArticleId><ArticleId IdType="pubmed">16298971</ArticleId></ArticleIdList></Reference><Reference><Citation>Hung H.C., Wang H.C., Shih S.R., Teng I.F., Tseng C.P., Hsu J.T. Synergistic inhibition of enterovirus 71 replication by interferon and rupintrivir. J. Infect. Dis. 2011;203:1784&#x2013;1790. doi: 10.1093/infdis/jir174.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jir174</ArticleId><ArticleId IdType="pubmed">21536800</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu J., Yi L., Zhao J., Yu J., Chen Y., Lin M.C., Kung H.F., He M.L. Enterovirus 71 disrupts interferon signaling by reducing the level of interferon receptor 1. J. Virol. 2012;86:3767&#x2013;3776. doi: 10.1128/JVI.06687-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.06687-11</ArticleId><ArticleId IdType="pmc">PMC3302529</ArticleId><ArticleId IdType="pubmed">22258259</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotenko S.V., Gallagher G., Baurin V.V., Lewis-Antes A., Shen M., Shah N.K., Langer J.A., Sheikh F., Dickensheets H., Donnelly R.P. IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat. Immunol. 2003;4:69&#x2013;77. doi: 10.1038/ni875.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni875</ArticleId><ArticleId IdType="pubmed">12483210</ArticleId></ArticleIdList></Reference><Reference><Citation>Ank N., West H., Bartholdy C., Eriksson K., Thomsen A.R., Paludan S.R. Lambda interferon (IFN-lambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo. J. Virol. 2006;80:4501&#x2013;4509. doi: 10.1128/JVI.80.9.4501-4509.2006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.80.9.4501-4509.2006</ArticleId><ArticleId IdType="pmc">PMC1472004</ArticleId><ArticleId IdType="pubmed">16611910</ArticleId></ArticleIdList></Reference><Reference><Citation>Ank N., West H., Paludan S.R. IFN-lambda: Novel antiviral cytokines. J. Interferon Cytokine Res. 2006;26:373&#x2013;379. doi: 10.1089/jir.2006.26.373.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/jir.2006.26.373</ArticleId><ArticleId IdType="pubmed">16734557</ArticleId></ArticleIdList></Reference><Reference><Citation>Pott J., Mahlakoiv T., Mordstein M., Duerr C.U., Michiels T., Stockinger S., Staeheli P., Hornef M.W. IFN-lambda determines the intestinal epithelial antiviral host defense. Proc. Natl. Acad. Sci. USA. 2011;108:7944&#x2013;7949. doi: 10.1073/pnas.1100552108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1100552108</ArticleId><ArticleId IdType="pmc">PMC3093475</ArticleId><ArticleId IdType="pubmed">21518880</ArticleId></ArticleIdList></Reference><Reference><Citation>Lind K., Svedin E., Utorova R., Stone V.M., Flodstrom-Tullberg M. Type III interferons are expressed by Coxsackievirus-infected human primary hepatocytes and regulate hepatocyte permissiveness to infection. Clin. Exp. Immunol. 2014;177:687&#x2013;695. doi: 10.1111/cei.12368.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cei.12368</ArticleId><ArticleId IdType="pmc">PMC4137853</ArticleId><ArticleId IdType="pubmed">24773058</ArticleId></ArticleIdList></Reference><Reference><Citation>Lind K., Richardson S.J., Leete P., Morgan N.G., Korsgren O., Flodstrom-Tullberg M. Induction of an antiviral state and attenuated coxsackievirus replication in type III interferon-treated primary human pancreatic islets. J. Virol. 2013;87:7646&#x2013;7654. doi: 10.1128/JVI.03431-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03431-12</ArticleId><ArticleId IdType="pmc">PMC3700265</ArticleId><ArticleId IdType="pubmed">23637411</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui S., Wang J., Fan T., Qin B., Guo L., Lei X., Wang J., Wang M., Jin Q. Crystal structure of human enterovirus 71 3C protease. J. Mol. Biol. 2011;408:449&#x2013;461. doi: 10.1016/j.jmb.2011.03.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2011.03.007</ArticleId><ArticleId IdType="pmc">PMC7094522</ArticleId><ArticleId IdType="pubmed">21396941</ArticleId></ArticleIdList></Reference><Reference><Citation>Shih S.R., Chiang C., Chen T.C., Wu C.N., Hsu J.T., Lee J.C., Hwang M.J., Li M.L., Chen G.W., Ho M.S. Mutations at KFRDI and VGK domains of enterovirus 71 3C protease affect its RNA binding and proteolytic activities. J. Biomed. Sci. 2004;11:239&#x2013;248. doi: 10.1007/BF02256567.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02256567</ArticleId><ArticleId IdType="pubmed">14966374</ArticleId></ArticleIdList></Reference><Reference><Citation>Sim A.C., Luhur A., Tan T.M., Chow V.T., Poh C.L. RNA interference against enterovirus 71 infection. Virology. 2005;341:72&#x2013;79. doi: 10.1016/j.virol.2005.06.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2005.06.047</ArticleId><ArticleId IdType="pubmed">16083932</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai Q., Yameen M., Liu W., Gao Z., Li Y., Peng X., Cai Y., Wu C., Zheng Q., Li J., et al. Conformational plasticity of the 2A proteinase from enterovirus 71. J. Virol. 2013;87:7348&#x2013;7356. doi: 10.1128/JVI.03541-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03541-12</ArticleId><ArticleId IdType="pmc">PMC3700279</ArticleId><ArticleId IdType="pubmed">23616646</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo R.L., Kao L.T., Lin S.J., Wang R.Y., Shih S.R. MDA5 plays a crucial role in enterovirus 71 RNA-mediated IRF3 activation. PLoS ONE. 2013;8:e63431. doi: 10.1371/journal.pone.0063431.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0063431</ArticleId><ArticleId IdType="pmc">PMC3641126</ArticleId><ArticleId IdType="pubmed">23650567</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J.P., Cerny A., Asher D.R., Kurt-Jones E.A., Bronson R.T., Finberg R.W. MDA5 and MAVS mediate type I interferon responses to coxsackie B virus. J. Virol. 2010;84:254&#x2013;260. doi: 10.1128/JVI.00631-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00631-09</ArticleId><ArticleId IdType="pmc">PMC2798442</ArticleId><ArticleId IdType="pubmed">19846534</ArticleId></ArticleIdList></Reference><Reference><Citation>Huhn M.H., McCartney S.A., Lind K., Svedin E., Colonna M., Flodstrom-Tullberg M. Melanoma differentiation-associated protein-5 (MDA-5) limits early viral replication but is not essential for the induction of type 1 interferons after Coxsackievirus infection. Virology. 2010;401:42&#x2013;48. doi: 10.1016/j.virol.2010.02.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2010.02.010</ArticleId><ArticleId IdType="pubmed">20206372</ArticleId></ArticleIdList></Reference><Reference><Citation>Barral P.M., Morrison J.M., Drahos J., Gupta P., Sarkar D., Fisher P.B., Racaniello V.R. MDA-5 is cleaved in poliovirus-infected cells. J. Virol. 2007;81:3677&#x2013;3684. doi: 10.1128/JVI.01360-06.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01360-06</ArticleId><ArticleId IdType="pmc">PMC1866155</ArticleId><ArticleId IdType="pubmed">17267501</ArticleId></ArticleIdList></Reference><Reference><Citation>Barral P.M., Sarkar D., Fisher P.B., Racaniello V.R. RIG-I is cleaved during picornavirus infection. Virology. 2009;391:171&#x2013;176. doi: 10.1016/j.virol.2009.06.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2009.06.045</ArticleId><ArticleId IdType="pmc">PMC2743091</ArticleId><ArticleId IdType="pubmed">19628239</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei X., Liu X., Ma Y., Sun Z., Yang Y., Jin Q., He B., Wang J. The 3C protein of enterovirus 71 inhibits retinoid acid-inducible gene I-mediated interferon regulatory factor 3 activation and type I interferon responses. J. Virol. 2010;84:8051&#x2013;8061. doi: 10.1128/JVI.02491-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02491-09</ArticleId><ArticleId IdType="pmc">PMC2916543</ArticleId><ArticleId IdType="pubmed">20519382</ArticleId></ArticleIdList></Reference><Reference><Citation>Slater L., Bartlett N.W., Haas J.J., Zhu J., Message S.D., Walton R.P., Sykes A., Dahdaleh S., Clarke D.L., Belvisi M.G., et al. Co-ordinated role of TLR3, RIG-I and MDA5 in the innate response to rhinovirus in bronchial epithelium. PLoSPathog. 2010;6:e1001178. doi: 10.1371/journal.ppat.1001178.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1001178</ArticleId><ArticleId IdType="pmc">PMC2973831</ArticleId><ArticleId IdType="pubmed">21079690</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei X., Sun Z., Liu X., Jin Q., He B., Wang J. Cleavage of the adaptor protein TRIF by enterovirus 71 3C inhibits antiviral responses mediated by Toll-like receptor 3. J. Virol. 2011;85:8811&#x2013;8818. doi: 10.1128/JVI.00447-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00447-11</ArticleId><ArticleId IdType="pmc">PMC3165803</ArticleId><ArticleId IdType="pubmed">21697485</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei X., Xiao X., Xue Q., Jin Q., He B., Wang J. Cleavage of interferon regulatory factor 7 by enterovirus 71 3C suppresses cellular responses. J. Virol. 2013;87:1690&#x2013;1698. doi: 10.1128/JVI.01855-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01855-12</ArticleId><ArticleId IdType="pmc">PMC3554134</ArticleId><ArticleId IdType="pubmed">23175366</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawai T., Akira S. Innate immune recognition of viral infection. Nat. Immunol. 2006;7:131&#x2013;137. doi: 10.1038/ni1303.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni1303</ArticleId><ArticleId IdType="pubmed">16424890</ArticleId></ArticleIdList></Reference><Reference><Citation>Ning S., Pagano J.S., Barber G.N. IRF7: Activation, regulation, modification and function. Genes Immun. 2011;12:399&#x2013;414. doi: 10.1038/gene.2011.21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/gene.2011.21</ArticleId><ArticleId IdType="pmc">PMC4437765</ArticleId><ArticleId IdType="pubmed">21490621</ArticleId></ArticleIdList></Reference><Reference><Citation>Akira S., Uematsu S., Takeuchi O. Pathogen recognition and innate immunity. Cell. 2006;124:783&#x2013;801. doi: 10.1016/j.cell.2006.02.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2006.02.015</ArticleId><ArticleId IdType="pubmed">16497588</ArticleId></ArticleIdList></Reference><Reference><Citation>Besse A., Lamothe B., Campos A.D., Webster W.K., Maddineni U., Lin S.C., Wu H., Darnay B.G. TAK1-dependent signaling requires functional interaction with TAB2/TAB3. J. Biol. Chem. 2007;282:3918&#x2013;3928. doi: 10.1074/jbc.M608867200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M608867200</ArticleId><ArticleId IdType="pmc">PMC3197015</ArticleId><ArticleId IdType="pubmed">17158449</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato S., Sanjo H., Takeda K., Ninomiya-Tsuji J., Yamamoto M., Kawai T., Matsumoto K., Takeuchi O., Akira S. Essential function for the kinase TAK1 in innate and adaptive immune responses. Nat. Immunol. 2005;6:1087&#x2013;1095. doi: 10.1038/ni1255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni1255</ArticleId><ArticleId IdType="pubmed">16186825</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei X., Han N., Xiao X., Jin Q., He B., Wang J. Enterovirus 71 3C inhibits cytokine expression through cleavage of the TAK1/TAB1/TAB2/TAB3 complex. J. Virol. 2014;88:9830&#x2013;9841. doi: 10.1128/JVI.01425-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01425-14</ArticleId><ArticleId IdType="pmc">PMC4136319</ArticleId><ArticleId IdType="pubmed">24942571</ArticleId></ArticleIdList></Reference><Reference><Citation>Takagaki Y., Manley J.L., MacDonald C.C., Wilusz J., Shenk T. A multisubunit factor, CstF, is required for polyadenylation of mammalian pre-mRNAs. Genes Dev. 1990;4:2112&#x2013;2120. doi: 10.1101/gad.4.12a.2112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.4.12a.2112</ArticleId><ArticleId IdType="pubmed">1980119</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng K.F., Li M.L., Hung C.T., Shih S.R. Enterovirus 71 3C protease cleaves a novel target CstF-64 and inhibits cellular polyadenylation. PLoSPathog. 2009;5:e1000593. doi: 10.1371/journal.ppat.1000593.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1000593</ArticleId><ArticleId IdType="pmc">PMC2742901</ArticleId><ArticleId IdType="pubmed">19779565</ArticleId></ArticleIdList></Reference><Reference><Citation>Noah D.L., Twu K.Y., Krug R.M. Cellular antiviral responses against influenza A virus are countered at the posttranscriptional level by the viral NS1A protein via its binding to a cellular protein required for the 3&#x2032; end processing of cellular pre-mRNAS. Virology. 2003;307:386&#x2013;395. doi: 10.1016/S0042-6822(02)00127-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0042-6822(02)00127-7</ArticleId><ArticleId IdType="pubmed">12667806</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsitsiou E., Lindsay M.A. microRNAs and the immune response. Curr. Opin. Pharmacol. 2009;9:514&#x2013;520. doi: 10.1016/j.coph.2009.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coph.2009.05.003</ArticleId><ArticleId IdType="pmc">PMC2742742</ArticleId><ArticleId IdType="pubmed">19525145</ArticleId></ArticleIdList></Reference><Reference><Citation>Lui Y.L., Tan T.L., Woo W.H., Timms P., Hafner L.M., Tan K.H., Tan E.L. Enterovirus71 (EV71) utilise host microRNAs to mediate host immune system enhancing survival during infection. PLoS ONE. 2014;9:e102997. doi: 10.1371/journal.pone.0102997.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0102997</ArticleId><ArticleId IdType="pmc">PMC4105423</ArticleId><ArticleId IdType="pubmed">25047717</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho B.C., Yu S.L., Chen J.J., Chang S.Y., Yan B.S., Hong Q.S., Singh S., Kao C.L., Chen H.Y., Su K.Y., et al. Enterovirus-induced miR-141 contributes to shutoff of host protein translation by targeting the translation initiation factor eIF4E. Cell Host Microbe. 2011;9:58&#x2013;69. doi: 10.1016/j.chom.2010.12.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2010.12.001</ArticleId><ArticleId IdType="pubmed">21238947</ArticleId></ArticleIdList></Reference><Reference><Citation>Sukhatme V.P., Cao X.M., Chang L.C., Tsai-Morris C.H., Stamenkovich D., Ferreira P.C., Cohen D.R., Edwards S.A., Shows T.B., Curran T., et al. A zinc finger-encoding gene coregulated with c-fos during growth and differentiation, and after cellular depolarization. Cell. 1988;53:37&#x2013;43. doi: 10.1016/0092-8674(88)90485-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(88)90485-0</ArticleId><ArticleId IdType="pubmed">3127059</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho B.C., Yu I.S., Lu L.F., Rudensky A., Chen H.Y., Tsai C.W., Chang Y.L., Wu C.T., Chang L.Y., Shih S.R., et al. Inhibition of miR-146a prevents enterovirus-induced death by restoring the production of type I interferon. Nat. Commun. 2014;5 doi: 10.1038/ncomms4344.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms4344</ArticleId><ArticleId IdType="pubmed">24561744</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu C., He X., Zheng Z., Zhang Z., Wei C., Guan K., Hou L., Zhang B., Zhu L., Cao Y., et al. Downregulation of microRNA miR-526a by enterovirus inhibits RIG-I-dependent innate immune response. J. Virol. 2014;88:11356&#x2013;11368. doi: 10.1128/JVI.01400-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01400-14</ArticleId><ArticleId IdType="pmc">PMC4178780</ArticleId><ArticleId IdType="pubmed">25056901</ArticleId></ArticleIdList></Reference><Reference><Citation>Oberste M.S., Penaranda S., Maher K., Pallansch M.A. Complete genome sequences of all members of the species Human enterovirus A. J. Gen. Virol. 2004;85:1597&#x2013;1607. doi: 10.1099/vir.0.79789-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.79789-0</ArticleId><ArticleId IdType="pubmed">15166444</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo R.L., Kung S.H., Hsu Y.Y., Liu W.T. Infection with enterovirus 71 or expression of its 2A protease induces apoptotic cell death. J. Gen. Virol. 2002;83:1367&#x2013;1376. doi: 10.1099/0022-1317-83-6-1367.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/0022-1317-83-6-1367</ArticleId><ArticleId IdType="pubmed">12029152</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin R., Lacoste J., Nakhaei P., Sun Q., Yang L., Paz S., Wilkinson P., Julkunen I., Vitour D., Meurs E., et al. Dissociation of a MAVS/IPS-1/VISA/Cardif-IKKepsilon molecular complex from the mitochondrial outer membrane by hepatitis C virus NS3-4A proteolytic cleavage. J. Virol. 2006;80:6072&#x2013;6083. doi: 10.1128/JVI.02495-05.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02495-05</ArticleId><ArticleId IdType="pmc">PMC1472616</ArticleId><ArticleId IdType="pubmed">16731946</ArticleId></ArticleIdList></Reference><Reference><Citation>Meylan E., Curran J., Hofmann K., Moradpour D., Binder M., Bartenschlager R., Tschopp J. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature. 2005;437:1167&#x2013;1172. doi: 10.1038/nature04193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature04193</ArticleId><ArticleId IdType="pubmed">16177806</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y., Liang Y., Qu L., Chen Z., Yi M., Li K., Lemon S.M. Disruption of innate immunity due to mitochondrial targeting of a picornaviral protease precursor. Proc. Natl. Acad. Sci. USA. 2007;104:7253&#x2013;7258. doi: 10.1073/pnas.0611506104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0611506104</ArticleId><ArticleId IdType="pmc">PMC1855380</ArticleId><ArticleId IdType="pubmed">17438296</ArticleId></ArticleIdList></Reference><Reference><Citation>Drahos J., Racaniello V.R. Cleavage of IPS-1 in cells infected with human rhinovirus. J. Virol. 2009;83:11581&#x2013;11587. doi: 10.1128/JVI.01490-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01490-09</ArticleId><ArticleId IdType="pmc">PMC2772720</ArticleId><ArticleId IdType="pubmed">19740998</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukherjee A., Morosky S.A., Delorme-Axford E., Dybdahl-Sissoko N., Oberste M.S., Wang T., Coyne C.B. The coxsackievirus B 3C protease cleaves MAVS and TRIF to attenuate host type I interferon and apoptotic signaling. PLoSPathog. 2011;7:e1001311.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3059221</ArticleId><ArticleId IdType="pubmed">21436888</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang B., Xi X., Lei X., Zhang X., Cui S., Wang J., Jin Q., Zhao Z. Enterovirus 71 protease 2Apro targets MAVS to inhibit anti-viral type I interferon responses. PLoSPathog. 2013;9:e1003231. doi: 10.1371/journal.ppat.1003231.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1003231</ArticleId><ArticleId IdType="pmc">PMC3605153</ArticleId><ArticleId IdType="pubmed">23555247</ArticleId></ArticleIdList></Reference><Reference><Citation>Triantafilou K., Vakakis E., Kar S., Richer E., Evans G.L., Triantafilou M. Visualisation of direct interaction of MDA5 and the dsRNA replicative intermediate form of positive strand RNA viruses. J. Cell Sci. 2012;125:4761&#x2013;4769. doi: 10.1242/jcs.103887.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.103887</ArticleId><ArticleId IdType="pubmed">22797917</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng Q., Langereis M.A., Lork M., Nguyen M., Hato S.V., Lanke K., Emdad L., Bhoopathi P., Fisher P.B., Lloyd R.E., et al. Enterovirus 2Apro targets MDA5 and MAVS in infected cells. J. Virol. 2014;88:3369&#x2013;3378. doi: 10.1128/JVI.02712-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02712-13</ArticleId><ArticleId IdType="pmc">PMC3957915</ArticleId><ArticleId IdType="pubmed">24390337</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrison J.M., Racaniello V.R. Proteinase 2Apro is essential for enterovirus replication in type I interferon-treated cells. J. Virol. 2009;83:4412&#x2013;4422. doi: 10.1128/JVI.02177-08.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02177-08</ArticleId><ArticleId IdType="pmc">PMC2668472</ArticleId><ArticleId IdType="pubmed">19211759</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu A.C., Parsons K., Barr I., Lowther S., Middleton D., Hansbro P.M., Wark P.A. Critical role of constitutive type I interferon response in bronchial epithelial cell to influenza infection. PLoS ONE. 2012;7:e32947. doi: 10.1371/journal.pone.0032947.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0032947</ArticleId><ArticleId IdType="pmc">PMC3292582</ArticleId><ArticleId IdType="pubmed">22396801</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Zhang Z., Zhao X., Yu R., Zhang X., Wu S., Liu J., Chi X., Song X., Fu L., et al. Enterovirus 71 inhibits cellular type I interferon signaling by downregulating JAK1 protein expression. Viral Immunol. 2014;27:267&#x2013;276. doi: 10.1089/vim.2013.0127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/vim.2013.0127</ArticleId><ArticleId IdType="pubmed">24905060</ArticleId></ArticleIdList></Reference><Reference><Citation>Bovee M.L., Marissen W.E., Zamora M., Lloyd R.E. The predominant elF4G-specific cleavage activity in poliovirus-infected HeLa cells is distinct from 2A protease. Virology. 1998;245:229&#x2013;240. doi: 10.1006/viro.1998.9171.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.1998.9171</ArticleId><ArticleId IdType="pubmed">9636362</ArticleId></ArticleIdList></Reference><Reference><Citation>Sommergruber W., Ahorn H., Klump H., Seipelt J., Zoephel A., Fessl F., Krystek E., Blaas D., Kuechler E., Liebig H.D., et al. 2A proteinases of coxsackie- and rhinovirus cleave peptides derived from eIF-4 gamma via a common recognition motif. Virology. 1994;198:741&#x2013;745. doi: 10.1006/viro.1994.1089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.1994.1089</ArticleId><ArticleId IdType="pubmed">8291255</ArticleId></ArticleIdList></Reference><Reference><Citation>Haghighat A., Svitkin Y., Novoa I., Kuechler E., Skern T., Sonenberg N. The eIF4G-eIF4E complex is the target for direct cleavage by the rhinovirus 2A proteinase. J. Virol. 1996;70:8444&#x2013;8450.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC190934</ArticleId><ArticleId IdType="pubmed">8970966</ArticleId></ArticleIdList></Reference><Reference><Citation>Baeuerle P.A., Baltimore D. NF-&#x3ba;B: Ten years after. Cell. 1996;87:13&#x2013;20. doi: 10.1016/S0092-8674(00)81318-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(00)81318-5</ArticleId><ArticleId IdType="pubmed">8858144</ArticleId></ArticleIdList></Reference><Reference><Citation>Pahl H.L. Activators and target genes of Rel/NF-&#x3ba;B transcription factors. Oncogene. 1999;18:6853&#x2013;6866. doi: 10.1038/sj.onc.1203239.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.onc.1203239</ArticleId><ArticleId IdType="pubmed">10602461</ArticleId></ArticleIdList></Reference><Reference><Citation>Hiscott J., Nguyen T.L., Arguello M., Nakhaei P., Paz S. Manipulation of the nuclear factor-&#x3ba;B pathway and the innate immune response by viruses. Oncogene. 2006;25:6844&#x2013;6867. doi: 10.1038/sj.onc.1209941.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.onc.1209941</ArticleId><ArticleId IdType="pmc">PMC7100320</ArticleId><ArticleId IdType="pubmed">17072332</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Z., Li H., Zhang Z., Meng J., Mao D., Bai B., Lu B., Mao P., Hu Q., Wang H. Enterovirus 71 2C protein inhibits TNF-&#x3b1;-mediated activation of NF-&#x3ba;B by suppressing I&#x3ba;B kinase &#x3b2; phosphorylation. J. Immunol. 2011;187:2202&#x2013;2212. doi: 10.4049/jimmunol.1100285.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1100285</ArticleId><ArticleId IdType="pubmed">21810613</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X., Song Z., Qin B., Zhang X., Chen L., Hu Y., Yuan Z. Rupintrivir is a promising candidate for treating severe cases of enterovirus-71 infection: Evaluation of antiviral efficacy in a murine infection model. Antivir. Res. 2013;97:264&#x2013;269. doi: 10.1016/j.antiviral.2012.12.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2012.12.029</ArticleId><ArticleId IdType="pubmed">23295352</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang L., Xu M., Yin Z. Antiviral drug discovery for the treatment of enterovirus 71 infections. Antivir. Res. 2013;97:183&#x2013;194. doi: 10.1016/j.antiviral.2012.12.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2012.12.005</ArticleId><ArticleId IdType="pubmed">23261847</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas A., Laxton C., Rodman J., Myangar N., Horscroft N., Parkinson T. Investigating Toll-like receptor agonists for potential to treat hepatitis C virus infection. Antimicrob. Agents Chemother. 2007;51:2969&#x2013;2978. doi: 10.1128/AAC.00268-07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.00268-07</ArticleId><ArticleId IdType="pmc">PMC1932540</ArticleId><ArticleId IdType="pubmed">17548497</ArticleId></ArticleIdList></Reference><Reference><Citation>Horsmans Y., Berg T., Desager J.P., Mueller T., Schott E., Fletcher S.P., Steffy K.R., Bauman L.A., Kerr B.M., Averett D.R. Isatoribine, an agonist of TLR7, reduces plasma virus concentration in chronic hepatitis C infection. Hepatology. 2005;42:724&#x2013;731. doi: 10.1002/hep.20839.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep.20839</ArticleId><ArticleId IdType="pubmed">16116638</ArticleId></ArticleIdList></Reference><Reference><Citation>Isogawa M., Robek M.D., Furuichi Y., Chisari F.V. Toll-like receptor signaling inhibits hepatitis B virus replication in vivo. J. Virol. 2005;79:7269&#x2013;7272. doi: 10.1128/JVI.79.11.7269-7272.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.79.11.7269-7272.2005</ArticleId><ArticleId IdType="pmc">PMC1112123</ArticleId><ArticleId IdType="pubmed">15890966</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J., Wu C.C., Lee K.J., Chuang T.H., Katakura K., Liu Y.T., Chan M., Tawatao R., Chung M., Shen C., et al. Activation of anti-hepatitis C virus responses via Toll-like receptor 7. Proc. Natl. Acad. Sci. USA. 2006;103:1828&#x2013;1833. doi: 10.1073/pnas.0510801103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0510801103</ArticleId><ArticleId IdType="pmc">PMC1413670</ArticleId><ArticleId IdType="pubmed">16446426</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammerbeck D.M., Burleson G.R., Schuller C.J., Vasilakos J.P., Tomai M., Egging E., Cochran F.R., Woulfe S., Miller R.L. Administration of a dual toll-like receptor 7 and toll-like receptor 8 agonist protects against influenza in rats. Antivir. Res. 2007;73:1&#x2013;11. doi: 10.1016/j.antiviral.2006.07.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2006.07.011</ArticleId><ArticleId IdType="pubmed">16959331</ArticleId></ArticleIdList></Reference><Reference><Citation>Cluff C.W., Baldridge J.R., Stover A.G., Evans J.T., Johnson D.A., Lacy M.J., Clawson V.G., Yorgensen V.M., Johnson C.L., Livesay M.T., et al. Synthetic toll-like receptor 4 agonists stimulate innate resistance to infectious challenge. Infect. Immun. 2005;73:3044&#x2013;3052. doi: 10.1128/IAI.73.5.3044-3052.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/IAI.73.5.3044-3052.2005</ArticleId><ArticleId IdType="pmc">PMC1087352</ArticleId><ArticleId IdType="pubmed">15845512</ArticleId></ArticleIdList></Reference><Reference><Citation>Ichinohe T., Watanabe I., Ito S., Fujii H., Moriyama M., Tamura S., Takahashi H., Sawa H., Chiba J., Kurata T., et al. Synthetic double-stranded RNA poly(I:C) combined with mucosal vaccine protects against influenza virus infection. J. Virol. 2005;79:2910&#x2013;2919. doi: 10.1128/JVI.79.5.2910-2919.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.79.5.2910-2919.2005</ArticleId><ArticleId IdType="pmc">PMC548446</ArticleId><ArticleId IdType="pubmed">15709010</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong J.P., Christopher M.E., Salazar A.M., Dale R.M., Sun L.Q., Wang M. Nucleic acid-based antiviral drugs against seasonal and avian influenza viruses. Vaccine. 2007;25:3175&#x2013;3178. doi: 10.1016/j.vaccine.2007.01.051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2007.01.051</ArticleId><ArticleId IdType="pubmed">17280757</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy O., Suter E.E., Miller R.L., Wessels M.R. Unique efficacy of Toll-like receptor 8 agonists in activating human neonatal antigen-presenting cells. Blood. 2006;108:1284&#x2013;1290. doi: 10.1182/blood-2005-12-4821.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2005-12-4821</ArticleId><ArticleId IdType="pmc">PMC1895876</ArticleId><ArticleId IdType="pubmed">16638933</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsiao H.B., Chou A.H., Lin S.I., Chen I.H., Lien S.P., Liu C.C., Chong P., Liu S.J. Toll-like receptor 9-mediated protection of enterovirus 71 infection in mice is due to the release of danger-associated molecular patterns. J. Virol. 2014;88:11658&#x2013;11670. doi: 10.1128/JVI.00867-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00867-14</ArticleId><ArticleId IdType="pmc">PMC4178751</ArticleId><ArticleId IdType="pubmed">25078697</ArticleId></ArticleIdList></Reference><Reference><Citation>Forrest S., Lear Z., Herod M.R., Ryan M., Rowlands D.J., Stonehouse N.J. Inhibition of the foot-and-mouth disease virus subgenomic replicon by RNA aptamers. J. Gen. Virol. 2014;95:2649&#x2013;2657. doi: 10.1099/vir.0.067751-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.067751-0</ArticleId><ArticleId IdType="pmc">PMC4233629</ArticleId><ArticleId IdType="pubmed">25096816</ArticleId></ArticleIdList></Reference><Reference><Citation>Woo H.M., Kim K.S., Lee J.M., Shim H.S., Cho S.J., Lee W.K., Ko H.W., Keum Y.S., Kim S.Y., Pathinayake P., et al. Single-stranded DNA aptamer that specifically binds to the influenza virus NS1 protein suppresses interferon antagonism. Antivir. Res. 2013;100:337&#x2013;345. doi: 10.1016/j.antiviral.2013.09.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2013.09.004</ArticleId><ArticleId IdType="pubmed">24055449</ArticleId></ArticleIdList></Reference><Reference><Citation>Ida-Hosonuma M., Iwasaki T., Yoshikawa T., Nagata N., Sato Y., Sata T., Yoneyama M., Fujita T., Taya C., Yonekawa H., et al. The &#x3b1;/&#x3b2; interferon response controls tissue tropism and pathogenicity of poliovirus. J. Virol. 2005;79:4460&#x2013;4469. doi: 10.1128/JVI.79.7.4460-4469.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.79.7.4460-4469.2005</ArticleId><ArticleId IdType="pmc">PMC1061561</ArticleId><ArticleId IdType="pubmed">15767446</ArticleId></ArticleIdList></Reference><Reference><Citation>Wessely R., Klingel K., Knowlton K.U., Kandolf R. Cardioselective infection with coxsackievirus B3 requires intact type I interferon signaling: Implications for mortality and early viral replication. Circulation. 2001;103:756&#x2013;761. doi: 10.1161/01.CIR.103.5.756.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.103.5.756</ArticleId><ArticleId IdType="pubmed">11156890</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>